Waiting lists are a reality of state AIDS Drug Assistance Programs (ADAPs), which rely on specific federal appropriations, or capped funding, each year. Capped funding determines ADAP’s income eligibility criteria, the number of drugs in the formulary, and the number of people who can be served. This fact sheet provides…
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
Overview and Briefing ChartsThis chartpack reviews the President’s FY 2006 budget request to Congress and highlights overall budget assumptions and funding for major health programs. It begins with a description of the federal budget process, followed by an overview of federal surplus/deficit spending patterns dating back to 1969. It then…
This data note examines public opinion among Washington, D.C.’s black residents about HIV/AIDS through a new analysis of the findings of the May 2011 Washington Post/Kaiser Family Foundation 2011 Survey of District of Columbia Residents. The District of Columbia has one of the highest AIDS rates in the nation, and…
Assessing Public Education Programming on HIV/AIDS: A National Survey of African Americans — Toplines
A new national survey of African Americans reviews aspects of the Rap It Up and KNOW HIV/AIDS campaigns, which are ongoing HIV/AIDS public education partnerships conducted by the Kaiser Family Foundation with Black Entertainment Television (BET) and Viacom, Inc., respectively. The survey seeks to look at the reach and impact…
Recent guidelines are all recommending that HIV treatment be started at a higher CD4 count because of issues such as the ongoing damage caused by HIV itself, and prevention of transmission. Issues in long-term treatment, such as potential side effects, the development of resistance, the cost and sustainability of programmes in resource-poor settings, are some of the potential problems for such a strategy.
HIV programs represent the first successful large-scale chronic disease program in resource-limited settings in history.
Human resources have challenged efforts to scale-up HIV prevention, care and treatment programs in low- and middle-income countries.
Following on the heels of The Lancet themed issue on HIV prevention launched at AIDS 2008, The Lancet has commissioned a series on the global HIV epidemic among people who use drugs.
AIDS 2010: Integrating Sexual and Reproductive Health and Rights (SRHR) and HIV: Lessons from the Field
At the International Conference on Population and Development in Cairo in 1994, governments worldwide agreed that sexual and reproductive health and rights include HIV services.
AIDS 2010: Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial
An update of current state of microbicide development will be provided. Speakers will provide a state of microbicide development update, safety and efficacy data from CAPRISA 004 and implications of the CAPRISA 004 trial results for the microbicide and PrEP field.